Stock SHANGPHARMA CORP (ADR)
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

ShangPharma Corp (ADR) Stock

Equities

US81943P1049

Biotechnology & Medical Research

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for ShangPharma Corp (ADR)
2014 AbbVie : board ditches planned $55 billion Shire acquisition RE

Latest news about ShangPharma Corp (ADR)

AbbVie : board ditches planned $55 billion Shire acquisition RE
More news

Press releases ShangPharma Corp (ADR)

ShangPharma Corp (ADR) : ShangPharma Announces Third Quarter 2012 Results PR
ShangPharma Corp (ADR) : ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012 PR
ShangPharma Corp (ADR) : ShangPharma and Harbour Antibodies Announce Licensing Agreement PR
ShangPharma Corp (ADR) : ShangPharma Announces Second Quarter 2012 Results PR
ShangPharma Corp (ADR) : ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012 PR
More press releases

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.90% 41.35B
LONZA GROUP AG Stock Lonza Group AG
+42.15% 40.38B
MODERNA, INC. Stock Moderna, Inc.
+1.88% 39.05B
CELLTRION, INC. Stock Celltrion, Inc.
-14.19% 26.67B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+1.56% 24.07B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.10% 18.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-4.00% 11.68B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+21.03% 11.6B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.14% 11.15B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock